Norris Perne & French LLP MI grew its stake in Danaher Corporation (NYSE:DHR) by 128.6% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 105,291 shares of the conglomerate’s stock after buying an additional 59,222 shares during the quarter. Danaher Corporation makes up 1.4% of Norris Perne & French LLP MI’s portfolio, making the stock its 26th biggest holding. Norris Perne & French LLP MI’s holdings in Danaher Corporation were worth $9,032,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently modified their holdings of DHR. GQG Partners LLC bought a new position in shares of Danaher Corporation in the second quarter worth about $101,000. Proficio Capital Partners LLC boosted its stake in shares of Danaher Corporation by 92.3% in the first quarter. Proficio Capital Partners LLC now owns 1,246 shares of the conglomerate’s stock worth $105,000 after acquiring an additional 598 shares during the period. Monetary Management Group Inc. boosted its stake in shares of Danaher Corporation by 10.7% in the second quarter. Monetary Management Group Inc. now owns 1,550 shares of the conglomerate’s stock worth $131,000 after acquiring an additional 150 shares during the period. Acrospire Investment Management LLC boosted its stake in shares of Danaher Corporation by 185.5% in the second quarter. Acrospire Investment Management LLC now owns 1,693 shares of the conglomerate’s stock worth $143,000 after acquiring an additional 1,100 shares during the period. Finally, Motco boosted its stake in shares of Danaher Corporation by 8.8% in the second quarter. Motco now owns 2,011 shares of the conglomerate’s stock worth $170,000 after acquiring an additional 163 shares during the period. Institutional investors and hedge funds own 75.56% of the company’s stock.

In other news, CFO Daniel L. Comas sold 88,184 shares of the stock in a transaction that occurred on Monday, October 23rd. The stock was sold at an average price of $91.02, for a total value of $8,026,507.68. Following the sale, the chief financial officer now directly owns 227,816 shares in the company, valued at $20,735,812.32. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, Director Donald J. Ehrlich sold 10,578 shares of the stock in a transaction that occurred on Tuesday, October 24th. The stock was sold at an average price of $90.82, for a total value of $960,693.96. Following the completion of the sale, the director now owns 104,621 shares in the company, valued at $9,501,679.22. The disclosure for this sale can be found here. Over the last quarter, insiders sold 317,498 shares of company stock worth $28,838,801. Company insiders own 12.20% of the company’s stock.

Shares of Danaher Corporation (DHR) opened at $93.30 on Monday. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.00 and a current ratio of 1.43. Danaher Corporation has a 52-week low of $76.27 and a 52-week high of $93.86. The stock has a market capitalization of $64,899.96, a P/E ratio of 23.99, a price-to-earnings-growth ratio of 2.22 and a beta of 1.02.

Danaher Corporation (NYSE:DHR) last issued its quarterly earnings results on Thursday, October 19th. The conglomerate reported $1.00 earnings per share for the quarter, topping the consensus estimate of $0.95 by $0.05. Danaher Corporation had a return on equity of 11.29% and a net margin of 13.36%. The firm had revenue of $4.53 billion for the quarter, compared to the consensus estimate of $4.47 billion. During the same period in the prior year, the business posted $0.87 earnings per share. The company’s revenue for the quarter was up 9.6% on a year-over-year basis. equities research analysts predict that Danaher Corporation will post 3.99 EPS for the current year.

The firm also recently declared a quarterly dividend, which was paid on Friday, October 27th. Stockholders of record on Friday, September 29th were issued a $0.14 dividend. The ex-dividend date was Thursday, September 28th. This represents a $0.56 annualized dividend and a dividend yield of 0.60%. Danaher Corporation’s payout ratio is 16.52%.

A number of research firms have recently weighed in on DHR. Goldman Sachs Group, Inc. (The) reaffirmed a “neutral” rating and issued a $83.00 price objective on shares of Danaher Corporation in a research note on Tuesday, September 26th. Jefferies Group LLC reaffirmed a “buy” rating and issued a $95.00 price objective on shares of Danaher Corporation in a research note on Friday, August 4th. BidaskClub lowered Danaher Corporation from a “sell” rating to a “strong sell” rating in a research note on Tuesday, August 1st. Zacks Investment Research lowered Danaher Corporation from a “buy” rating to a “hold” rating in a research note on Thursday, July 27th. Finally, Robert W. Baird increased their price target on Danaher Corporation from $87.00 to $97.00 and gave the company an “outperform” rating in a research note on Friday, October 20th. One research analyst has rated the stock with a sell rating, four have issued a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Danaher Corporation has an average rating of “Buy” and an average target price of $93.31.

TRADEMARK VIOLATION WARNING: This article was originally reported by Daily Political and is the property of of Daily Political. If you are viewing this article on another website, it was stolen and republished in violation of U.S. & international trademark and copyright laws. The correct version of this article can be accessed at https://www.dailypolitical.com/2017/11/20/norris-perne-french-llp-mi-has-9-03-million-holdings-in-danaher-corporation-dhr.html.

Danaher Corporation Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Institutional Ownership by Quarter for Danaher Corporation (NYSE:DHR)

Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.